Drug Type Biological products |
Synonyms CRES 101, CRES101 |
Target- |
Mechanism- |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Sclerosis | Preclinical | NO | 30 Nov 2022 | |
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Preclinical | NO | 30 Nov 2022 | |
Streptococcal Infections | Preclinical | NO | 30 Nov 2022 |